Concepedia

Shebli Atrash

SA

31

Publications

1.1K

Citations

18

H-Index

2011

Active since

Affiliations

Levine Cancer Institute(Current)

University of Kansas Medical Center

University of Utah

Stanford University

Virginia Commonwealth University

Shebli Atrash is an author at Levine Cancer Institute specializing in medicine, immunotherapy, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2011–2025

31

Publications

31

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Doris K. Hansen, Surbhi Sidana, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 257 citations · Full text

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi et al. · Blood Cancer Journal · 2023 · 96 citations · Full text

Safety and efficacy of standard-of-care ciltacabtagene autoleucel for relapsed/refractory multiple myeloma

Surbhi Sidana, Krina K. Patel, Lauren C. Peres et al. · Blood · 2024 · 92 citations · Full text

Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma: influence of thalidomide and lenalidomide during maintenance

Saad Z. Usmani, Rachel Sexton, Antje Hoering et al. · Blood · 2012 · 76 citations · Full text

Patterns of Central Nervous System Involvement in Relapsed and Refractory Multiple Myeloma

Al‐Ola Abdallah, Shebli Atrash, Zainab Shahid et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 61 citations

, , +6

Rows per page

1–5 of 31